Literature DB >> 34708256

Prediction of successful trial of labor after cesarean among grand-multiparous women.

Gabriel Levin1,2, Abraham Tsur3,4, Lee Tenenbaum4, Nizan Mor4, Michal Zamir4, Raanan Meyer3,4.   

Abstract

PURPOSE: To determine the factors associated with successful trial of labor after cesarean (TOLAC) among grand-multiparous (GMP) women.
METHODS: A retrospective cohort study was conducted, including all GMP women (≥ 5 deliveries) undergoing TOLAC during 3/2011 and 6/2020, delivering a singleton cephalic newborn. Factors associated with successful vaginal delivery were examined by multivariable analysis.
RESULTS: Overall, 381/413 (92.2%) GMP succeeded TOLAC. Maternal characteristics did not differ between TOLAC success and TOLAC failure groups. Previous cesarean delivery characteristics did not differ between study groups. The median number of previous vaginal births after cesarean was 2 [interquartile range 1-4]. Gestational age at TOLAC was lower in the success group (mean 371/7 ± 36/7 vs. 385/7 ± 31/7 weeks, p = 0.028). A lower rate of modified Bishop score < 4 was associated with TOLAC success [149 (39.1%) vs. 22 (69%), odds ratio (OR) 95% confidence interval (CI) 0.29 (0.13-0.64), p = 0.001]. The rate of induction of labor was higher in the TOLAC failure group [120 (31.5%) vs. 17 (53%), OR 95% CI 0.40 (0.19-0.83), p = 0.013]. The rate of oxytocin administration was higher in the TOLAC failure group [94 (24.7%) vs. 15 (47%) OR (95% CI) 0.37 (0.17-0.77), p = 0.006]. The duration of rupture of membranes was negatively associated with TOLAC success. Neonatal and maternal adverse outcomes did not differ between study groups. In multivariable logistic regression analysis, only the duration of rupture of membranes and modified Bishop score < 4 were independently associated with TOLAC success [adjusted OR (95% CI) 0.98 (0.96-0.99), p = 0.027 and 0.40 (0.16-0.97), p = 0.044].
CONCLUSION: TOLAC among GMP has a very-high success rate. Shortening the duration of ruptured membranes is a modifiable factor that may be associated with increased TOLAC success rates.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cesarean delivery; Grand multiparous; Trial of labor; Uterine rupture; Vaginal birth

Mesh:

Year:  2021        PMID: 34708256     DOI: 10.1007/s00404-021-06311-4

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.493


  5 in total

1.  Trial of labor after previous single cesarean delivery in grand-multiparous women: a retrospective cohort study.

Authors:  Maya Ram; Liran Hiersch; Eran Ashwal; Yariv Yogev; Amir Aviram
Journal:  Arch Gynecol Obstet       Date:  2021-01-03       Impact factor: 2.344

2.  Vaginal birth after cesarean section: is suspected fetal macrosomia a contraindication?

Authors:  B L Flamm; J R Goings
Journal:  Obstet Gynecol       Date:  1989-11       Impact factor: 7.661

3.  Safety of induction of labor with vaginal prostaglandins (e2) in grandmultipara.

Authors:  Veena Paliwal; Sushma Dikhit; Sonal Singh
Journal:  Oman Med J       Date:  2009-07

4.  Factors associated with the use of intrapartum epidural analgesia.

Authors:  W J Hueston; R R McClaflin; C J Mansfield; M Rudy
Journal:  Obstet Gynecol       Date:  1994-10       Impact factor: 7.661

5.  Neonatal outcome of second-stage cesarean delivery versus vacuum extraction among neonates <34 weeks.

Authors:  Gabriel Levin; Amihai Rottenstreich; Abraham Tsur; Tal Cahan; Joshua I Rosenbloom; Simcha Yagel; Raanan Meyer
Journal:  J Matern Fetal Neonatal Med       Date:  2020-12-01
  5 in total
  2 in total

1.  Outcomes and risk factors for failed trial of labor after cesarean delivery (TOLAC) in women with one previous cesarean section: a Chinese population-based study.

Authors:  Xiaobo He; Qiaona Dai; Xiaoli Wu; Junjun Zhou; Jie Li
Journal:  BMC Pregnancy Childbirth       Date:  2022-09-03       Impact factor: 3.105

2.  Maternal and neonatal characteristics associated with clinical outcomes of TOLAC from 2012-20 in the USA: Evidence from a retrospective cohort study.

Authors:  Hanxu Shi; Siwen Li; Jin Lv; Harry H X Wang; Qingxiang Hou; Yinzi Jin
Journal:  EClinicalMedicine       Date:  2022-09-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.